Ligand Information
| Ligand General Information | Top | |||
|---|---|---|---|---|
| Ligand ID |
LIZ7P3
|
|||
| Ligand Name |
MLi-2-Bio-X
|
|||
| Synonyms |
MLI-2; 1627091-47-7; MLi-2 - Bio-X; (2~{r},6~{s})-2,6-Dimethyl-4-[6-[5-(1-Methylcyclopropyl)oxy-1~{h}-Indazol-3-Yl]pyrimidin-4-Yl]morpholine; (2S,6R)-2,6-dimethyl-4-(6-(5-(1-methylcyclopropoxy)-1H-indazol-3-yl)pyrimidin-4-yl)morpholine; Merck lrrk2 inhibitor-2; CHEMBL4098877; SCHEMBL16022474; GTPL11663; CHEBI:132484; EX-A4118; AKOS030210950; AT22709; compound 1 [PMID: 28245354]; CS-6349; AC-36550; AS-76747; HY-100411; S9694; J3.645.913A; Q27225595; cis-2,6-dimethyl-4-(6-(5-(1-methylcyclopropoxy)-1H-indazol-3-yl)pyrimidin-4-yl)morpholine; (2R,6S)-2,6-dimethyl-4-(6-(5-(1-methylcyclopropoxy)-1H-indazol-3-yl)pyrimidin-4-yl)morpholine; (2R,6S)-2,6-dimethyl-4-[6-[5-(1-methylcyclopropyl)oxy-1H-indazol-3-yl]pyrimidin-4-yl]morpholine; 5-(1-Methylcyclopropane-1-yloxy)-3-[6-(2beta,6beta-dimethylmorpholine-4-yl)pyrimidine-4-yl]-1H-indazole; A1N; rel-(2S,6R)-2,6-Dimethyl-4-(6-(5-(1-methylcyclopropoxy)-1H-indazol-3-yl)pyrimidin-4-yl)morpholine; rel-3-[6-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-4-pyrimidyl]-5-[(1-methylcyclopropyl)oxy]-1H-indazole
Click to Show/Hide
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H25N5O2
|
|||
| Canonical SMILES |
CC1CN(CC(O1)C)C2=NC=NC(=C2)C3=NNC4=C3C=C(C=C4)OC5(CC5)C
|
|||
| InChI |
1S/C21H25N5O2/c1-13-10-26(11-14(2)27-13)19-9-18(22-12-23-19)20-16-8-15(28-21(3)6-7-21)4-5-17(16)24-25-20/h4-5,8-9,12-14H,6-7,10-11H2,1-3H3,(H,24,25)/t13-,14+
|
|||
| InChIKey |
ATUUNJCZCOMUKD-OKILXGFUSA-N
|
|||
| PubChem Compound ID | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.